HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade.

Abstract
Ang II acting at AT(1)Rs has well documented effects on cardiovascular structure such as the promotion of cardiovascular hypertrophy and fibrosis, effects which are believed to be opposed by AT(2)R stimulation. AT(1) and AT(2)R expression are up regulated in senescent hearts, and other components of the local renin-angiotensin system are also dramatically increased in the ageing heart. Therefore, the aim of this study was to determine the role of the AT(2)R in aged rats by determining their potential contribution to the chronic antihypertensive and cardiovascular effects of AT(1)R blockade. Radiotelemetry probes were implanted into senescent (20 months) male Wistar-Kyoto (WKY) rats, and baseline recordings of mean arterial pressure (MAP) were made for 1 week. Candesartan cilexetil (2 mg/kg per day) was given in drinking water, while an additional group simultaneously received the AT(2)R antagonist, PD123319 (10 mg/kg per day) via osmotic mini-pump. At the end of the 4 weeks treatment period, animals were perfusion-fixed to enable histological analysis of cardiovascular structure. MAP was decreased by candesartan cilexetil, however, this effect was not further influenced by PD123319. Cardiac hypertrophy and fibrosis, and aortic hypertrophy were all significantly reduced by candesartan cilexetil. Most interestingly, these structural changes were reversed by concomitant PD123319 administration, despite the lack of AT(2)R-mediated effects on MAP. These results suggest that the AT(2)R does not exert a significant influence on chronic blood pressure regulation in senescent rats. However, PD123319 did reverse AT(1)R-mediated regression of cardiovascular hypertrophy and fibrosis, highlighting the important role of the AT(2)R on cardiovascular structure in the ageing heart and vasculature.
AuthorsEmma S Jones, M Jane Black, Robert E Widdop
JournalJournal of molecular and cellular cardiology (J Mol Cell Cardiol) Vol. 37 Issue 5 Pg. 1023-30 (Nov 2004) ISSN: 0022-2828 [Print] England
PMID15522279 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin II Type 2 Receptor Blockers
  • Benzimidazoles
  • Biphenyl Compounds
  • Imidazoles
  • Pyridines
  • Receptor, Angiotensin, Type 2
  • Tetrazoles
  • Angiotensin II
  • PD 123319
  • candesartan cilexetil
Topics
  • Aging (physiology)
  • Angiotensin II (physiology)
  • Angiotensin II Type 1 Receptor Blockers (pharmacology)
  • Angiotensin II Type 2 Receptor Blockers
  • Animals
  • Aorta (pathology)
  • Benzimidazoles (pharmacology)
  • Biphenyl Compounds (pharmacology)
  • Blood Pressure (drug effects, physiology)
  • Cardiomegaly (etiology, pathology)
  • Fibrosis
  • Heart Rate (drug effects, physiology)
  • Hypertrophy (pathology)
  • Imidazoles (pharmacology)
  • Myocardium (pathology)
  • Pyridines (pharmacology)
  • Rats
  • Rats, Inbred WKY
  • Receptor, Angiotensin, Type 2 (physiology)
  • Telemetry
  • Tetrazoles (pharmacology)
  • Ventricular Remodeling (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: